# CorePharma, LLC, Middlesex, NJ – FDA Inspections

Source: https://www.keypedia.com/companies/corepharma-llc/037e485c-5d38-40e3-80fe-b00a72cda489

> Inspection records and compliance data for CorePharma, LLC in Middlesex, New Jersey. 14 FDA inspections on record (3 OAI), last inspected August 28, 2025.

---

## Details

- Name: CorePharma, LLC
- FEI Number: 3002535019
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK
- Address Line 1: 215 Wood Ave
- City: Middlesex
- State: New Jersey
- Zip Code: 08846
- Country Name: United States
- Address: 215 Wood Ave, Middlesex, New Jersey 08846, United States
- Country: United States

## Related Documents

- FDA Inspection 1280399 - CorePharma, LLC - 2025-08-28 — source: FDA, date: August 28, 2025
- [FDA Inspection 1280399 - CorePharma, LLC - 2025-08-28](https://www.keypedia.com/records/fda_inspections/corepharma-llc/a79456c1-10bd-4a42-b391-e30e7bd8084c) — classification: No Action Indicated (NAI), source: FDA, date: August 28, 2025
- FDA Inspection 1240419 - CorePharma, LLC - 2024-09-12 — source: FDA, date: September 12, 2024
- [FDA Inspection 1240419 - CorePharma, LLC - 2024-09-12](https://www.keypedia.com/records/fda_inspections/corepharma-llc/debe7cb9-f65c-449a-8bd8-1fa4d1291653) — classification: No Action Indicated (NAI), source: FDA, date: September 12, 2024
- [EIR - CorePharma, LLC - 2019-12-13](https://www.keypedia.com/records/eir/corepharma-llc/87a03a3a-e46c-42f7-9858-c004cff68a0b) — source: FDA, date: December 13, 2019
- FDA Inspection 1087306 - CorePharma, LLC - 2019-03-29 — classification: No Action Indicated (NAI), source: FDA, date: March 29, 2019
- FDA Inspection 1029942 - CorePharma, LLC - 2017-10-13 — classification: No Action Indicated (NAI), source: FDA, date: October 13, 2017
- FDA Inspection 980585 - CorePharma, LLC - 2016-08-11 — classification: No Action Indicated (NAI), source: FDA, date: August 11, 2016
- FDA Inspection 915404 - CorePharma, LLC - 2015-02-24 — classification: No Action Indicated (NAI), source: FDA, date: February 24, 2015
- FDA Inspection 890789 - CorePharma, LLC - 2014-08-12 — classification: No Action Indicated (NAI), source: FDA, date: August 12, 2014
- FDA Inspection 867056 - CorePharma, LLC - 2014-02-21 — classification: No Action Indicated (NAI), source: FDA, date: February 21, 2014

## Related Companies

- [Exelead, Inc.](https://www.keypedia.com/companies/exelead-inc/ca24adb3-36c5-4253-a831-dc2328d3c9d7)
- [PAI Holdings, LLC. dba Pharmaceutical Associates Inc](https://www.keypedia.com/companies/pai-holdings-llc-dba-pharmaceutical-associates-inc/b93f9b61-624a-4cd9-925c-039200bc1e79)
- [Heritage Pharmaceuticals, Inc. DBA AVET Pharmaceutical LABS](https://www.keypedia.com/companies/heritage-pharmaceuticals-inc-dba-avet-pharmaceutical-labs/d1b6ef2c-8d4d-40d5-88e0-f80f0bb351f9)
- [Istituto Biochimico Italiano Giovanni Lorenzini S.p.A.](https://www.keypedia.com/companies/istituto-biochimico-italiano-giovanni-lorenzini-spa/15ae51d8-a4ba-42a6-9100-2d04641f2514)
- [Polygen Pharmaceuticals Inc.](https://www.keypedia.com/companies/polygen-pharmaceuticals-inc/d7df0d1f-787a-4629-b096-255e664d26ef)
- [Citragen Pharmaceuticals Inc](https://www.keypedia.com/companies/citragen-pharmaceuticals-inc/c9428b65-fa89-4165-8df5-4b2ae89afc03)
- [Sofgen Pharmaceuticals LLC](https://www.keypedia.com/companies/sofgen-pharmaceuticals-llc/4bf867c1-4886-43a8-b3a1-3d027c2307b8)
- [ANSTO Nuclear Medicine](https://www.keypedia.com/companies/ansto-nuclear-medicine/9bb26b43-b1c1-4d57-9008-7563e01d67e2)
- [Zydus Hospira Oncology Private Ltd.](https://www.keypedia.com/companies/zydus-hospira-oncology-private-ltd/1daf2047-24d1-4343-9500-8a3c69eccaf4)
- [Opella Healthcare International SAS](https://www.keypedia.com/companies/opella-healthcare-international-sas/53ed93ee-b631-49a0-bba2-a57194143394)

## Related Officers

- [Lata C. Mathew](https://www.keypedia.com/people/lata-c-mathew/0610a0ef-dcc5-43e7-ab74-2ac54d758beb)
- [company_representative](https://www.keypedia.com/people/vithal-dhaduk/3bbc2792-954c-45bc-b0ac-b9b17cab934d)